Effectiveness and Implementation of a Personalized mHealth Intervention for the Universal Prevention of Maternal Perinatal Mental Disorders (ePerinatal-RCT)
25 de maio de 2026 atualizado por: Emma Motrico, University of Seville
Universal Prevention of Maternal Perinatal Mental Disorders and Its Implementation as Normalized Routine Practice (e-Perinatal): A Cluster Randomized Hybrid Effectiveness-Implementation Trial
This study is part of the ERC-funded e-Perinatal project and represents a large-scale hybrid type 1 effectiveness-implementation cluster randomized controlled trial.
The primary aim is to evaluate the effectiveness of a personalized and complex mobile health (mHealth) intervention (e-Perinatal) in the universal prevention of maternal perinatal depression and anxiety disorders.
Secondary aims include evaluating the impact on paternal mental health and child development, as well as examining implementation outcomes in real-world primary healthcare settings.
Visão geral do estudo
Status
Ainda não está recrutando
Condições
Descrição detalhada
This clinical trial evaluates the effectiveness and implementation of the e-Perinatal intervention, a personalized mobile health (mHealth) psychological program designed for the universal prevention of maternal perinatal depression and anxiety disorders. The study will be conducted as a two-arm, cluster-randomized, hybrid type 1 effectiveness-implementation trial in routine maternal care settings within primary healthcare centers.
Primary healthcare centers will be randomized to either the intervention or control arm. Participants will include pregnant women and their partners.
The primary objective is to evaluate the effectiveness of the e-Perinatal intervention in reducing the cumulative incidence of maternal perinatal depression and anxiety disorders, assessed via structured diagnostic interviews. Secondary objectives include assessing maternal and paternal mental health outcomes, child development outcomes, and identifying moderators and mediators of intervention effectiveness.
In addition, the study will evaluate implementation outcomes, including acceptability, feasibility, adoption, fidelity, and barriers and facilitators to implementation in real-world healthcare settings.
Participants in the intervention group will receive access to the e-Perinatal app alongside usual maternal care. The e-Perinatal app includes: 1) Digital micro-interventions focused on psychological, physical activity, and healthy lifestyle domains; 2) a personalized recommendation engine; 3) a social support section; 4) mental health monitoring; 5) an 'SOS' button for assistance; and 6) an appointment reminder tool. Participants in the control group will receive usual maternal care.
Tipo de estudo
Intervencional
Inscrição (Estimado)
3000
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Emma Motrico, PhD Psychology
- Número de telefone: 0034636995778
- E-mail: eperinatal@us.es
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Sim
Descrição
Inclusion Criteria:
- Inclusion Criteria (Women)
Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers
Must be pregnant for at least 11 weeks at the time of enrollment
Must be at least 18 years old
Must have access to a mobile phone and internet connection
Must be able to read, write, and understand Spanish
Must have a personal email account
No diagnosis of depression or anxiety disorder at baseline Forma
- Inclusion Criteria (Partners or significant others)
Must receive an invitation to participate from a woman already enrolled in the study
Must be at least 18 years old
Must have access to a mobile phone and internet connection
Must be able to read, write, and understand Spanish
Must have a personal email account
Exclusion Criteria:
- Exclusion Criteria (Women)
Current diagnosis of depression or anxiety disorder
Receiving psychological or pharmacological treatment for mental health or substance use conditions
- Exclusion criteria for partners (or significant others):
There are no exclusion criteria for partners
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Grupo de intervenção
|
The e-Perinatal intervention is a personalized mobile health (mHealth) program that includes: 1) Digital micro-interventions focused on psychological, physical activity, and healthy lifestyle domains; 2) a personalized recommendation engine; 3) a social support section; 4) mental health monitoring; 5) an 'SOS' button for assistance; and 6) an appointment reminder tool. The intervention is delivered through a mobile application and is integrated into routine maternal care. Participants will use the app from recruitment (pregnancy) until 12 months of postpartum. |
|
Comparador Ativo: Grupo de controle
|
Participants will receive standard maternal care as provided by the public healthcare system, including routine antenatal and postnatal visits and access to maternal education programs.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cumulative incidence of maternal perinatal depression and anxiety disorders
Prazo: Baseline and 12 months postpartum
|
Assessment method: Composite Internacional Diagnosis Interview (CIDI), based on DSM-5 criteria
|
Baseline and 12 months postpartum
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Maternal depressive symptoms (mothers)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in depressive symptoms.
Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Maternal anxiety symptoms (mothers)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in anxiety symptoms.
Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Paternal depressive symptoms (partner)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in depressive symptoms.
Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Paternal anxiety symptoms (partner)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in anxiety symptoms.
Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure.
Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
|
Psychological well-being (mothers, partners)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Changes in subjective well-being.
Assessment method: The Well-Being Index (WHO-5), a 5-item self-report measure.
Each item is scored from 0 to 5, with higher scores indicating better subjective well-being.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks), 6 weeks postpartum, and 6, 12, and 18 months postpartum
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Prontidão organizacional para implementar mudanças
Prazo: Medido antes do recrutamento
|
Prontidão da organização para implementar mudanças nos cuidados habituais.
Método de avaliação: A Prontidão Organizacional Implementando Mudanças (ORIC), uma medida de autorrelato de 12 itens.
Cada item é pontuado de 1 a 5, sendo que pontuações mais altas indicam maior prontidão para implementar mudanças.
|
Medido antes do recrutamento
|
|
Características da APS
Prazo: Medido antes do recrutamento
|
Tamanho da população onde está localizada a APS e número de profissionais da APS.
Método de avaliação: Questionário desenvolvido pela equipa de investigação
|
Medido antes do recrutamento
|
|
App quality (mothers, partners)
Prazo: 12 months postpartum
|
Objective and subjective quality, and the perceived impact of the application.
Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating better app quality.
|
12 months postpartum
|
|
Implementation process
Prazo: 12 months postpartum
|
App implementation process from the perspective of healthcare professionals involved in implementing complex interventions.
Assessment method: The Normalization Measure Development Questionnaire (NoMAD), a 20-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating more effective implementation processes.
|
12 months postpartum
|
|
Barriers and facilitators
Prazo: 12 months postpartum
|
Identifies barriers and facilitators impacting the integration of the intervention into routine healthcare, drawing from the experiences of users and healthcare professionals.
Assessment method: Semi-structured interviews following the Normalization Process Theory (NPT) framework
|
12 months postpartum
|
|
Reasons for dropout (mothers, partners)
Prazo: 12 months postpartum
|
Number and reasons (e.g., experienced miscarriage or stillbirth, lack of engagement with the app) for dropout among women and their partners.
Assessment method: Records and semi structured interviews.
|
12 months postpartum
|
|
Antenatal and postnatal risks (mothers, partners)
Prazo: Baseline, 6 weeks postpartum
|
Measures both antenatal and postnatal risk factors.
Assessment method: The Antenatal Risk Questionnaire (ANRQ-R), a 11-item self-report measure.
Some items are scored from 1 to 5 and others are scored on categorical scale, with higher scores indicating greater risk.
|
Baseline, 6 weeks postpartum
|
|
Basic psychological needs (mothers, partners)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the satisfaction and frustration of basic psychological needs.
Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale).
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Maternal post-traumatic stress symptoms (mothers)
Prazo: 6 weeks postpartum
|
Presence of post-traumatic stress symptoms after childbirth.
Assessment method: City Birth Trauma Scale (City-BiTS), a 5-item self-report measure.
A total of 4 items are scored from 0 to 3 and one item is scored from 0 to 1, with higher scores indicating greater severity of postnatal post-traumatic stress.
|
6 weeks postpartum
|
|
Maternal perceptions of childbirth (mothers)
Prazo: 6 weeks postpartum
|
Measure of the perceived quality of the childbirth experience.
Assessment method: Childbirth Experience Questionnaire (CEQ-E), a 22-items self-report scale.
A total of 19 items range from 1 to 4. A total of 2 items range from 0 to 10. Higher scores indicate a more positive experience of childbirth.
|
6 weeks postpartum
|
|
Maternal breastfeeding experience (mothers)
Prazo: 6 weeks postpartum; 6 months postpartum
|
Assessment method: Ad hoc instrument.
The instrument assesses infant feeding practices (2 items) and maternal satisfaction with breastfeeding (1 item), yielding a score ranging from 0 to 100.
Higher scores indicate greater satisfaction with breastfeeding.
|
6 weeks postpartum; 6 months postpartum
|
|
Maternal antenatal attachment (mothers)
Prazo: 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the level of maternal antenatal attachment to the baby.
Assessment method: The Maternal Antenatal Attachment Scale (MAAS), a 19-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger maternal antenatal attachment.
|
34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Paternal antenatal attachment (partners)
Prazo: 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the level of paternal antenatal attachment to the baby.
Assessment method: The Paternal Antenatal Attachment Scale (PAAS), a 16-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger paternal antenatal attachment.
|
34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Maternal postnatal attachment (mothers)
Prazo: 6 weeks postpartum
|
Measures the level of maternal postnatal attachment to the baby.
Assessment method: The Maternal Postnatal Attachment Scale (MPAS), a 19-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger maternal postnatal attachment.
|
6 weeks postpartum
|
|
Paternal postnatal attachment (fathers)
Prazo: 6 weeks postpartum
|
Measures the level of postnatal attachment to the baby in both mothers and fathers.
Assessment method: The Paternal Postnatal Attachment Scale (PPAS), a 19-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating stronger paternal postnatal attachment.
|
6 weeks postpartum
|
|
Psychological flexibility (mothers, partner)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measure of psychological flexibility.
Assessment method: Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT), a 10-item self-report scale.
Each item is scored from 1 to 7, with higher scores indicating greater psychological flexibilityTime
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Partnership quality (mothers, partners)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measures the quality of the marital or partnership relationship.
Assessment method: The Quality of Marriage Index (QMI), a 6-item self-report measure.
Some items are scored from 1 to 7 and others from 1 to 10, with higher scores indicating better relationship quality.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Parental role perception (mothers)
Prazo: 6 months postpartum
|
Measures parents' perception of their competence in the parental role.
Assessment method: The Parental Sense of Competence scale (PSOC), a 21-item self-report measure.
Each item is scored from 1 to 6, with higher scores indicating a stronger sense of parental competence.
|
6 months postpartum
|
|
Coparenting dynamics (mothers, partners)
Prazo: 6 months postpartum
|
Measures the dynamics of coparenting relationships.
Assessment method: The Coparenting Relationship Scale (CRS), a 14-item self-report measure.
Each item is scored from 0 to 6, with higher scores indicating more positive coparenting dynamics.
|
6 months postpartum
|
|
Mediterranean diet adherence (mothers, partners)
Prazo: Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
Measure of adherence to the mediterranean diet.
Assessment method: Mediterranean Diet Adherence Screener (MEDAS), a 14-items self-report instrument.
Each item score from 0 to 1. Higher scores indicate greater adherence to the mediterranean diet.
|
Baseline, 34-36 weeks of gestation (for participants enrolled before 31 weeks)
|
|
Maternal physical activity levels (mothers)
Prazo: Baseline, 6 months postpartum
|
Measures physical activity levels in pregnant women and mothers.
Assessment method: The Pregnancy Physical Activity Questionnaire (PPAQ), a 33-item self-report measure.
Each item is scored from 0 to 5, with higher scores indicating higher levels of physical activity.
|
Baseline, 6 months postpartum
|
|
Physical condition (mothers)
Prazo: Baseline, 6 months postpartum
|
Measures overall physical condition and the main components (i.e., cardiorespiratory fitness, muscular strength, speed-agility, and flexibility) in pregnant women and mothers.
Assessment method: The International FItness Scale (IFIS), a 5-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating better physical condition.
|
Baseline, 6 months postpartum
|
|
Child temperament (mothers)
Prazo: 6 months postpartum
|
Measures various aspect of infant temperament.
Assessment method: The Infant Behavior Questionnaire-Revised Short Form (IBQ-R SF), a 37-item self-report measure.
Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.
|
6 months postpartum
|
|
Child development (mothers)
Prazo: 6 months postpartum
|
Measures of various domains of infant development. Assessment method: Ages & Stages Questionnaires (ASQ-3), a self-report measure. Each milestone question is answered using one of three frequency options, which are converted into point values:
|
6 months postpartum
|
|
Life quality (mothers, partners)
Prazo: 12 months postpartum
|
Measures the overall quality of life.
Assessment method: The European Quality of Life-5 Dimensions-5 Levels (EuroQol-5D-5L), a 5-item self-report measure.
Each item is scored from 1 to 5, with higher scores indicating worse quality of life
|
12 months postpartum
|
|
Identity (mothers, partners)
Prazo: Baseline, 6 months postpartum
|
Measure of various domains of identity development.
Assessment method: Dimensions of Identity Development Scale (DIDS)., a 25-items self-report measure.
Each item is scored from 1 to 5, with higher scores indicating greater endorsement of the corresponding identity development dimension.
|
Baseline, 6 months postpartum
|
|
Economic data
Prazo: 12 months postpartum
|
Measures healthcare service utilization and sick leave days over the previous year among participating women.
Assessment method: a post hoc semi-structured interview that collects information on emergency visits, hospital admissions, primary care visits (e.g., nurse, midwife, social worker), secondary care visits, and consultations with specialists.
|
12 months postpartum
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Emma Motrico, PhD, University of Seville
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Estimado)
30 de maio de 2026
Conclusão Primária (Estimado)
30 de dezembro de 2027
Conclusão do estudo (Estimado)
30 de março de 2028
Datas de inscrição no estudo
Enviado pela primeira vez
6 de maio de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
25 de maio de 2026
Primeira postagem (Real)
29 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
29 de maio de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
25 de maio de 2026
Última verificação
1 de maio de 2026
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- EP-WP3-2025
- 101042139 (Outro identificador: European Research Council (ERC))
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Depressão perinatal
-
University of WashingtonConcluídoDepressão perinatal | Ansiedade perinatal | Estresse parentalEstados Unidos
-
National Taiwan University HospitalAinda não está recrutandoDepressão perinatal | Ansiedade perinatal | Saúde Mental MaternaTaiwan
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH)Ainda não está recrutandoDepressão perinatal | Sensibilidade à Ansiedade | Ansiedade perinatal
-
Beth Israel Deaconess Medical CenterNational Institute of Mental Health (NIMH)RecrutamentoDepressão perinatal | Ansiedade perinatalEstados Unidos
-
Sameera ShafiqConcluídoDepressão perinatal | Ansiedade perinatalPaquistão
-
University of YalovaAinda não está recrutando
-
Fundación IVIConcluídoDistúrbio perinatalItália, Espanha, Reino Unido
-
PulseNmoreUniversity of MichiganConcluídoAssistência PerinatalEstados Unidos
-
PulseNmoreConcluído
-
Universite du Quebec en OutaouaisFonds de la Recherche en Santé du Québec; Canadian Research Chair in Family...Desconhecido